Fate Therapeutics (NasdaqGM:FATE) FY Conference April 14, 2026 03:45 PM ET Company ParticipantsBob Valamehr - President and CEOConference Call ParticipantsGil Blum - Senior Biotech AnalystGil BlumGood afternoon, everyone and thank you for joining me at the second day of the Needham Healthcare Conference. My name is Gil Blum, and I'm a Senior Biotech Analyst here at Needham & Company, and I cover the cell and gene therapy space. It is my pleasure to have with me today, Bob Valamehr, the President and CEO of ...